Gynesonics Announces New SMART OS™ Software Technology for Sonata® System Treatment of Uterine Fibroids
26. September 2024 08:30 ET
|
Gynesonics
REDWOOD CITY, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Gynesonics Inc., a medical device company focused on the development of minimally invasive solutions for symptomatic uterine fibroids,...
U.S. Women's Health Market Size, Share & Trends Analysis Report 2024-2030: Hormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, PCOS
20. September 2024 04:04 ET
|
Research and Markets
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "U.S. Women's Health Market Size, Share & Trends Analysis Report By Application (Contraceptives, Endometriosis & Uterine Fibroids), By Age (50...
United States Endometriosis and Uterine Fibroids Markets, 2020-2024 & 2025-2030: Rise in Non-Invasive Drug Therapies Driving Growth, Online Pharmacies Set to Revolutionize Distribution
19. September 2024 07:25 ET
|
Research and Markets
Dublin, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The "United States Endometriosis and Uterine Fibroids Market (2024 Edition): Analysis By Drug Type, By Route of Administration, By Distribution Channel, By...
Women's Reproductive Health Market (2024 Edition): Market Insights and Forecast (2020-2030) Featuring Profiles of Amgen, Teva Pharma, Merck & Co, Bayer, AbbVie
18. September 2024 04:14 ET
|
Research and Markets
Dublin, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The "Women Reproductive Health Market (2024 Edition): Market Insights and Forecast (2020-2030)" report has been added to ResearchAndMarkets.com's...
Global $67B+ Women's Health Market Landscape 2024-2030: Analysis by Age, Application and Region
11. Januar 2024 12:43 ET
|
Research and Markets
Dublin, Jan. 11, 2024 (GLOBE NEWSWIRE) -- The "Global Women's Health Market Size, Share & Trends Analysis Report by Application (Postmenopausal Osteoporosis, Infertility, Endometriosis &...
Global Uterine Fibroids Treatment Market Report to 2027: Players Include Myovant Sciences, Gynesonics, Medtronic and Boston Scientific
09. Februar 2023 11:43 ET
|
Research and Markets
Dublin, Feb. 09, 2023 (GLOBE NEWSWIRE) -- The "Uterine Fibroids Treatment Market- Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027)" report has been added to ResearchAndMarkets.com's...
Global Uterine Fibroids Clinical Landscape Market Report 2021 - Repros Therapeutics has the Highest Number of Completed Clinical Trials with 17
17. Juni 2021 04:18 ET
|
Research and Markets
Dublin, June 17, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Uterine Fibroids" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the Uterine...